From smaller incisions and less pain to shorter hospital stays and faster recovery times, robotic-assisted surgery is changing the way patients experience surgical care.

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Domestic violence claimed the lives of 160 Texans in 2025, according to a report released October 1, 2026, by the Texas Council on Family Violence (TCFV), documenting the continuing impact of intimate partner violence across the state.

Becoming an angel for someone facing cancer may be as simple as donating $3 or $5. Through DHR Health’s annual Bras for a Cause fundraiser, community members can help patients experiencing financial difficulties while supporting breast cancer awareness and early detection.